Lumen Technologies holds Q1 2026 earnings call

Lumen Technologies conducted its first-quarter 2026 earnings conference call on May 5, 2026. CEO Kathleen Johnson and President and CFO Christopher Stansbury presented to analysts. The call included standard forward-looking statement disclaimers.

The earnings call took place at 5:00 PM EDT on Tuesday, May 5, 2026. James Breen, Senior Vice President of Investor Relations, opened the session by thanking participants and issuing reminders about forward-looking statements under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. He noted that actual results may differ due to risks detailed in recent SEC filings, including the Form 10-K and Q1 Form 10-Q, and that the company does not plan to update these statements unless required. Conference call participants included analysts from Citigroup, Raymond James, TD Cowen, BofA Securities, MoffettNathanson, and UBS. The operator introduced the speakers and confirmed the call was being recorded. Breen then turned the conference over to CEO Kate Johnson and President and CFO Chris Stansbury for the main presentation.

Awọn iroyin ti o ni ibatan

Illumina Inc. conducted its first-quarter 2026 earnings conference call on April 30, 2026, at 4:30 PM EDT. CEO Jacob Thaysen and CFO Ankur Dhingra presented updates on the business and financial results. The company released its earnings after market close, available on its investor relations website.

Ti AI ṣe iroyin

Atlassian Corporation conducted its third quarter fiscal 2026 earnings conference call on April 30, 2026, at 5:00 PM EDT. CEO Mike Cannon-Brookes and CFO James Chuong joined Head of Investor Relations Martin Lam to discuss results. The company published its shareholder letter and press release earlier that day.

Broadcom Inc. held its first quarter fiscal year 2026 earnings conference call on March 4, 2026. The company shared financial performance details via a press release distributed after market close. Executives including CEO Hock Tan and CFO Kirsten Spears participated in the discussion.

Ti AI ṣe iroyin

BioMarin Pharmaceutical Inc. conducted its first-quarter 2026 earnings conference call on May 4, 2026. Company executives, including CEO Alexander Hardy, presented financial results and updates. The call included forward-looking statements and non-GAAP measures.

 

 

 

Ojú-ìwé yìí nlo kuki

A nlo kuki fun itupalẹ lati mu ilọsiwaju wa. Ka ìlànà àṣírí wa fun alaye siwaju sii.
Kọ